Figure 3

Kaplan–Meier curves of outcomes associated with specific lipoxygenases (LOXs) catalyzed arachidonic acid metabolites in patients with coronary artery disease. The rates of freedom from acute myocardial infarction are shown: (A) 8-HETE ≥ 30.92 ng/mL vs. 8-HETE < 30.92 ng/mL; (B) 9-HETE ≥ 4.28 ng/mL vs. 9-HETE < 4.28 ng/mL (p < 0.001); (C) 11-HETE ≥ 4.77 ng/mL vs. 11-HETE < 4.77 ng/mL; (D) 12-HETE ≥ 17.39 ng/mL vs. 12-HETE < 17.39 ng/mL; (E) 15-HETE ≥ 32.37 ng/mL vs. 15-HETE < 32.37 ng/mL.